According to the recent study the interventional cardiology and peripheral vascular device market is projected to reach an estimated $38 billion by 2030 from $26 billion in 2023 at a CAGR of 6% from 2023 to 2030. Growth in this market is primarily driven by growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.
A more than 150–page
report is developed to understand trends, opportunities and forecast in
interventional cardiology and peripheral vascular device market by type
(interventional cardiology and peripheral vascular device), device (angioplasty
balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC
filter, embolic protection device, guidewires, arteriotomy closure device,
intravascular ultrasound system, and synthetic surgical graft), end user
(hospitals and ambulatory surgical centers), and region (North America, Europe,
Asia Pacific, and the Rest of the World).
Lucintel forecasts that
interventional cardiology and peripheral vascular devices is expected to
witness significant growth over the forecast period because of new technology
innovations and aging population.
Within global interventional
cardiology and peripheral vascular device market, the largest segment by end
user is projected to be hospitals due to the growing public-private
partnerships to improve access to healthcare services along with rapid
developments in healthcare infrastructure and improving access to healthcare
services. These are the major driving factors for growth in this segment over
the forecast period.
Download sample by clicking on interventional cardiology and
peripheral vascular device market
APAC is expected to
remain the largest region because it is a large pharmaceutical manufacturing
base and it is witnessing increasing technological advancements in
interventional cardiology and peripheral vascular devices.
APAC is expected to
witness the highest growth rate over the forecast period due to the presence of
a large pool of respiratory patients, increasing healthcare expenditure,
rapidly developing healthcare infrastructure, rising per capita income, growing
middle-class population, and growing prevalence of tobacco smoking in this
region.
Abbott Laboratories,
Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics
Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo
Corporation, Cardinal Health Inc are the major suppliers in the interventional
cardiology and peripheral vascular device providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com To get
access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Automotive Digital Signal Controller Market
Automotive Dry Air Filter Market
Automotive Fuel Return Line Market
No comments:
Post a Comment